Missed
At its July 16 2019 launch event Neuralink, with Musk presenting, said it aimed to start testing on human patients in 2020 pending FDA approval. That did not happen; FDA human-trial approval came in May 2023 and the first human Neuralink implant was performed in late January 2024 (announced by Musk Jan 29 2024). The 2020 target was missed by more than three years. MIT Technology Review, July 17 2019 — Neuralink's plan to begin human testing in 2020; cross-checked against Wikipedia/Neuralink timeline for the Jan 2024 first implant ↗
Human trials by 2020 was unveiled in July 2019 with Elon Musk stating that Neuralink is looking to start trials on humans next year. Patients with severe brain injuries, such as those from stroke, cancer lesions, or congenital conditions, are affected and waiting for potential treatments. This follows Neuralink's pattern of similar predictions, including animal tests on rats and monkeys that demonstrated brain-controlled computing. The initiative matters as it aims to secure FDA approval for clinical trials, enabling brain-computer interfaces to restore functions like speech and sight while aligning with broader healthcare technology trends.
Missed
Delivered · Late
Delivered